Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.53B |
| 2 |
NVIDIA
NVDA
|
+$1.07B |
| 3 |
Capital One
COF
|
+$1.02B |
| 4 |
Apple
AAPL
|
+$998M |
| 5 |
Amazon
AMZN
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DFS
Discover Financial Services
DFS
|
+$1.09B |
| 2 |
Palantir
PLTR
|
+$671M |
| 3 |
Coca-Cola
KO
|
+$501M |
| 4 |
Qualcomm
QCOM
|
+$435M |
| 5 |
Applovin
APP
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.45% |
| 2 | Financials | 14.05% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.36% |
| 5 | Communication Services | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGMA
3976
DELISTED
Sigmatron International
SGMA
| $140K | ﹤0.01% |
46,949
| – | – |
|
3977
PharmaCyte Biotech
PMCB
$5.81M
| $139K | ﹤0.01% |
126,603
-12,332
| -9% | -$13.8K |
|
3978
MultiSensor AI
MSAI
$11.1M
| $138K | ﹤0.01% |
5,787
+72
| +1% | +$2.27K |
|
|
ACB
3979
Aurora Cannabis
ACB
$234M
| $138K | ﹤0.01% |
32,619
+133
| +0.4% | +$645 |
|
3980
Urban One Class A
UONE
$23.3M
| $138K | ﹤0.01% |
8,527
+106
| +1% | +$1.64K |
|
|
AXIL
3981
AXIL Brands
AXIL
$38.9M
| $138K | ﹤0.01% |
25,101
+962
| +4% | +$5.6K |
|
3982
Natural Alternatives International
NAII
$13.2M
| $138K | ﹤0.01% |
41,983
-1,650
| -4% | -$5.26K |
|
|
TRT
3983
Trio-Tech International
TRT
$116M
| $138K | ﹤0.01% |
50,778
+820
| +2% | +$2.16K |
|
|
TBHC
3984
DELISTED
The Brand House Collective
TBHC
| $136K | ﹤0.01% |
125,915
-4,745
| -4% | -$5.62K |
|
3985
Phio Pharmaceuticals
PHIO
$12.4M
| $136K | ﹤0.01% |
57,694
+16,108
| +39% | +$32.6K |
|
|
GLBZ
3986
DELISTED
Glen Burnie Bancorp
GLBZ
| $135K | ﹤0.01% |
26,841
+253
| +1% | +$1.26K |
|
|
PONY
3987
Pony AI Inc
PONY
$3.53B
| $135K | ﹤0.01% |
10,200
+42
| +0.4% | +$507 |
|
3988
Envoy Medical
COCH
$57.4M
| $134K | ﹤0.01% |
94,131
-101
| -0.1% | -$148 |
|
3989
BranchOut Food
BOF
$65.4M
| $134K | ﹤0.01% |
55,006
+1,740
| +3% | +$3.52K |
|
3990
Exicure
XCUR
$8.54M
| $134K | ﹤0.01% |
18,963
-135
| -0.7% | -$1.37K |
|
|
NBP
3991
NovaBridge Biosciences American Depositary Shares
NBP
$214M
| $132K | ﹤0.01% |
54,562
+32,525
| +148% | +$44.1K |
|
|
EDHL
3992
Everbright Digital
EDHL
$6.37M
| $132K | ﹤0.01% |
+1,373
| New | +$99.5K |
|
|
RITR
3993
Reitar Logtech Holdings
RITR
$8.74M
| $131K | ﹤0.01% |
+29,330
| New | +$118K |
|
3994
Xos
XOS
$35.8M
| $131K | ﹤0.01% |
43,388
+261
| +0.6% | +$885 |
|
3995
ALX Oncology
ALXO
$274M
| $131K | ﹤0.01% |
315,421
-455,486
| -59% | -$230K |
|
3996
Cingulate
CING
$69.1M
| $131K | ﹤0.01% |
32,156
+1,756
| +6% | +$7.17K |
|
3997
Similarweb
SMWB
$752M
| $131K | ﹤0.01% |
16,731
-16,999
| -50% | -$127K |
|
3998
Minerva Neurosciences
NERV
$199M
| $130K | ﹤0.01% |
75,625
-1,107
| -1% | -$1.81K |
|
3999
AC Immune
ACIU
$265M
| $129K | ﹤0.01% |
63,601
-489
| -0.8% | -$851 |
|
4000
BioVie
BIVI
$13M
| $129K | ﹤0.01% |
13,940
+138
| +1% | +$1.36K |
|
Similar funds
Geode Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Geode Capital Management held 4,594 positions worth $1.43T, up 12% from $1.27T the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Geode Capital Management's Q2 2025 filing shows 119 new, 2,787 increased, 1,425 reduced and 150 closed positions. Its largest new stake was Emera Inc: 3,219,448 shares worth $152M. The largest sale was Discover Financial Services, an estimated $1.09B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geode Capital Management's largest Q2 2025 buy was Emera Inc: 3,219,448 shares worth $152M.
- Geode Capital Management added most to Microsoft in Q2 2025, an estimated $1.53B increase.
- Geode Capital Management's biggest Q2 2025 reduction was Palantir, cutting an estimated $671M.
- Geode Capital Management fully exited Discover Financial Services in Q2 2025, selling an estimated $1.09B.
- Geode Capital Management's ten largest holdings make up 32% of its $1.43T portfolio in Q2 2025.
- Geode Capital Management opened 119 new positions and closed 150 in Q2 2025.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $1.43T.
Based on Geode Capital Management's 13F filing for Q2 2025, filed 8 Aug 2025.